Senior Counsel, Corporate, Securities & Transactions

Allogene Therapeutics

South San Francisco, CA

JOB DETAILS
SALARY
$250,000–$280,000 Per Year
SKILLS
Alliance/Partner Management, Analysis Skills, Autoimmune Disease, Biology, Biotech and Pharmaceutical, Business Development, Cancer, Communication Skills, Contract Negotiation, Corporate Compliance, Corporate Governance, Corporate Law, Corporate Policies, Cross-Functional, Diversity, Documentation, Due Diligence, Finance, Investor Relations, Legal, Licensing, Logistics, Mergers and Acquisitions, Negotiation Skills, Project/Program Management, Proxy Statement, Regulations, SEC Filings, Sales Pipeline, Securities, Stock Administration
LOCATION
South San Francisco, CA
POSTED
Today

About Allogene:

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.

About the role:

Reporting to the General Counsel, the Senior Counsel, Corporate, Securities & Transactions will work closely with the General Counsel on Allogene’s public company corporate legal function, including SEC reporting, corporate governance, Board and committee matters, proxy and annual meeting processes, Section 16 reporting, and related disclosure and compliance matters. The role will also support strategic transactions, business development activities, M&A, licensing and collaboration matters, and the drafting and negotiation of corporate and commercial agreements. This position is hybrid and based at Allogene’s headquarters in South San Francisco, CA.

Responsibilities include, but are not limited to:

  • Work closely with the General Counsel to draft, review and coordinate SEC filings, including Forms 10-K, 10-Q, 8-K, proxy statements, Section 16 filings, and other public company disclosures.
  • Advise on corporate governance matters, including Board and committee materials, governance policies, Nasdaq compliance, Delaware corporate law matters, director and officer questionnaires, insider trading policies, Regulation FD and public company best practices.
  • Support Board and committee processes, including preparation and review of meeting materials, resolutions, minutes, consents and related governance documentation.
  • Support the Company’s annual meeting and proxy season process, including proxy statement preparation, shareholder meeting logistics and related governance matters.
  • Partner with Finance, Investor Relations, People/HR, Stock Administration and outside advisors on disclosure, equity compensation, executive compensation and public company compliance matters.
  • Draft, review and negotiate agreements related to strategic partnerships, business development, licensing, collaborations, M&A, confidentiality, services and other corporate or commercial matters.
  • Support legal aspects of strategic transactions, including due diligence, transaction documentation, internal approvals and post-signing implementation.
  • Help manage outside counsel in areas of responsibility.
  • Provide practical, business-oriented legal advice to cross-functional teams in a fast-paced public company biotechnology environment.
  • Other duties as assigned.

Position Requirements & Experience:

  • J.D. from an accredited law school and membership in good standing in at least one U.S. state bar. California bar admission or eligibility to register as California in-house counsel required.
  • At least 8 years of relevant corporate/securities experience, preferably including significant experience at a nationally recognized law firm and/or in-house public company legal department.
  • Significant experience advising public companies on SEC reporting, corporate governance, proxy statements, annual meetings, Section 16 reporting and related disclosure matters.
  • Experience with Board and committee support, corporate governance policies, Nasdaq/listing requirements, Delaware corporate law, insider trading policies and Regulation FD.
  • Experience drafting and negotiating corporate or commercial agreements; experience with strategic partnerships, licensing, collaborations, M&A or other business development transactions strongly preferred.
  • Life sciences, biotechnology, or pharmaceutical industry experience preferred.
  • Ability to work closely with senior executives and Board members, exercise sound judgment and provide practical, business-oriented legal advice.
  • Excellent drafting, analytical, project management and communication skills.
  • Ability to work independently while collaborating closely with the General Counsel and cross-functional teams.
  • Candidates must be authorized to work in the U.S.

We offer a chance to work with talented people in a collaborative environment and provide a top-notch compensation and benefits package, which includes an annual performance bonus, equity, health insurance, generous time off (including 2 annual holiday company-wide shutdowns) and much more. The expected salary range for this role is $250,000 to $280,000 per year. Actual pay will be determined based on experience, qualifications, geographic location, business needs, and other job-related factors permitted by law.

As an equal opportunity employer, Allogene is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job-related characteristics or other prohibited grounds specified in applicable federal, state and local laws. We also embrace differences in experience and background, and welcome diversity of opinions and thought, designed to create a stronger and better Allogene that is focused on developing life-changing products for patients.

#LI-TF1

About the Company

A

Allogene Therapeutics